Turner syndrome: searching for better outcomes

OBJECTIVES: To assess the results of growth hormone on the growth of girls with Turner Syndrome and identify relevant parameters to improve outcomes. METHODS: Growth velocity and final height were studied in a historical cohort of 41 girls, regularly followed up for hormone distribution at three ref...

Full description

Bibliographic Details
Main Authors: Adauto Versiani Ramos, Ivani Novato Silva, Eugênio Marcos Andrade Goulart
Format: Article
Language:English
Published: Faculdade de Medicina / USP 2008-01-01
Series:Clinics
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322008000200004
id doaj-7026fdb63acd4b3eba15bc5df707a44f
record_format Article
spelling doaj-7026fdb63acd4b3eba15bc5df707a44f2020-11-24T23:30:39ZengFaculdade de Medicina / USPClinics1807-59321980-53222008-01-0163217317810.1590/S1807-59322008000200004Turner syndrome: searching for better outcomesAdauto Versiani RamosIvani Novato SilvaEugênio Marcos Andrade GoulartOBJECTIVES: To assess the results of growth hormone on the growth of girls with Turner Syndrome and identify relevant parameters to improve outcomes. METHODS: Growth velocity and final height were studied in a historical cohort of 41 girls, regularly followed up for hormone distribution at three referral centers. The influence of oxandrolone and of estrogens on the final height was analyzed. The girls (initial chronological age=8.9&plusmn;3.4years; initial bone age=7.0&plusmn;3.1years) used 0.19 mg/kg/week of growth hormone for 4.0 &plusmn; 2.0 years. RESULTS: In the first year, growth velocity increased by 71.5% in 41 girls and 103.4% in those who reached final height (11 girls). The whole group had a gain in the height SDS of 0.8 &plusmn; 0.7 (p<0.01) and for those who reached a final height of 1.0 &plusmn; 0.8 (p<0.01). Final height (143.6 &plusmn;6.3 cm) was 3.9 &plusmn; 5.3 cm higher than the predicted height, and the height gain occurred before estrogen therapy. Oxandrolone had no significant influence on height gain. The significant variables contributing to the final height were the duration of growth hormone used and its use prior to starting estrogens, the initial height SDS, and the growth velocity during the first year of treatment. CONCLUSIONS: We concluded that the use of growth hormone significantly increased the final height, which remained lower than the target. Results point to a need for starting growth hormone use as early as possible and to maximize treatment before estrogen replacement. It has been observed that even moderate doses of growth hormone may significantly increase early growth velocity.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322008000200004GrowthGrowth velocityAdult heightGrowth hormoneTurner syndrome
collection DOAJ
language English
format Article
sources DOAJ
author Adauto Versiani Ramos
Ivani Novato Silva
Eugênio Marcos Andrade Goulart
spellingShingle Adauto Versiani Ramos
Ivani Novato Silva
Eugênio Marcos Andrade Goulart
Turner syndrome: searching for better outcomes
Clinics
Growth
Growth velocity
Adult height
Growth hormone
Turner syndrome
author_facet Adauto Versiani Ramos
Ivani Novato Silva
Eugênio Marcos Andrade Goulart
author_sort Adauto Versiani Ramos
title Turner syndrome: searching for better outcomes
title_short Turner syndrome: searching for better outcomes
title_full Turner syndrome: searching for better outcomes
title_fullStr Turner syndrome: searching for better outcomes
title_full_unstemmed Turner syndrome: searching for better outcomes
title_sort turner syndrome: searching for better outcomes
publisher Faculdade de Medicina / USP
series Clinics
issn 1807-5932
1980-5322
publishDate 2008-01-01
description OBJECTIVES: To assess the results of growth hormone on the growth of girls with Turner Syndrome and identify relevant parameters to improve outcomes. METHODS: Growth velocity and final height were studied in a historical cohort of 41 girls, regularly followed up for hormone distribution at three referral centers. The influence of oxandrolone and of estrogens on the final height was analyzed. The girls (initial chronological age=8.9&plusmn;3.4years; initial bone age=7.0&plusmn;3.1years) used 0.19 mg/kg/week of growth hormone for 4.0 &plusmn; 2.0 years. RESULTS: In the first year, growth velocity increased by 71.5% in 41 girls and 103.4% in those who reached final height (11 girls). The whole group had a gain in the height SDS of 0.8 &plusmn; 0.7 (p<0.01) and for those who reached a final height of 1.0 &plusmn; 0.8 (p<0.01). Final height (143.6 &plusmn;6.3 cm) was 3.9 &plusmn; 5.3 cm higher than the predicted height, and the height gain occurred before estrogen therapy. Oxandrolone had no significant influence on height gain. The significant variables contributing to the final height were the duration of growth hormone used and its use prior to starting estrogens, the initial height SDS, and the growth velocity during the first year of treatment. CONCLUSIONS: We concluded that the use of growth hormone significantly increased the final height, which remained lower than the target. Results point to a need for starting growth hormone use as early as possible and to maximize treatment before estrogen replacement. It has been observed that even moderate doses of growth hormone may significantly increase early growth velocity.
topic Growth
Growth velocity
Adult height
Growth hormone
Turner syndrome
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322008000200004
work_keys_str_mv AT adautoversianiramos turnersyndromesearchingforbetteroutcomes
AT ivaninovatosilva turnersyndromesearchingforbetteroutcomes
AT eugeniomarcosandradegoulart turnersyndromesearchingforbetteroutcomes
_version_ 1725540994489778176